A citation-based method for searching scientific literature

Mary Linton Peters, Judy E Garber, Nadine Tung. Gynecol Oncol 2017
Times Cited: 8







List of co-cited articles
21 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers.
Neda Stjepanovic, Jan Lubinski, Pal Moller, Susan Randall Armel, William D Foulkes, Nadine Tung, Susan L Neuhausen, Joanne Kotsopoulos, Ping Sun, Sophie Sun,[...]. Breast Cancer Res Treat 2021
1
100

Routine TP53 testing for breast cancer under age 30: ready for prime time?
Jeanna M McCuaig, Susan R Armel, Ana Novokmet, Ophira M Ginsburg, Rochelle Demsky, Steven A Narod, David Malkin. Fam Cancer 2012
57
12

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015
280
12

Early onset HER2-positive breast cancer is associated with germline TP53 mutations.
Amal Melhem-Bertrandt, Jasmina Bojadzieva, Kaylene J Ready, Elias Obeid, Diane D Liu, Angelica M Gutierrez-Barrera, Jennifer K Litton, Olufunmilayo I Olopade, Gabriel N Hortobagyi, Louise C Strong,[...]. Cancer 2012
85
12

Population Frequency of Germline BRCA1/2 Mutations.
Kara N Maxwell, Susan M Domchek, Katherine L Nathanson, Mark E Robson. J Clin Oncol 2016
66
12

Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk.
Monica Marabelli, Su-Chun Cheng, Giovanni Parmigiani. Genet Epidemiol 2016
59
12

Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
N J H van Os, N Roeleveld, C M R Weemaes, M C J Jongmans, G O Janssens, A M R Taylor, N Hoogerbrugge, M A A P Willemsen. Clin Genet 2016
90
12

A systematic review and meta-analysis of family history and risk of ovarian cancer.
J F Stratton, P Pharoah, S K Smith, D Easton, B A Ponder. Br J Obstet Gynaecol 1998
147
12

Inherited p53 gene mutations in breast cancer.
D Sidransky, T Tokino, K Helzlsouer, B Zehnbauer, G Rausch, B Shelton, L Prestigiacomo, B Vogelstein, N Davidson. Cancer Res 1992
212
12

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016
220
12

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer.
Ana M Gonzalez-Angulo, Kirsten M Timms, Shuying Liu, Huiqin Chen, Jennifer K Litton, Jennifer Potter, Jerry S Lanchbury, Katherine Stemke-Hale, Bryan T Hennessy, Banu K Arun,[...]. Clin Cancer Res 2011
362
12

The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.
P Hartge, J P Struewing, S Wacholder, L C Brody, M A Tucker. Am J Hum Genet 1999
160
12

The risk of developing second cancers among survivors of childhood soft tissue sarcoma.
Randi J Cohen, Rochelle E Curtis, Peter D Inskip, Joseph F Fraumeni. Cancer 2005
62
12

Highly penetrant hereditary cancer syndromes.
Rebecca Nagy, Kevin Sweet, Charis Eng. Oncogene 2004
194
12

CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls.
Maren Weischer, Stig Egil Bojesen, Christina Ellervik, Anne Tybjaerg-Hansen, Børge Grønne Nordestgaard. J Clin Oncol 2008
192
12


Genetic susceptibility to triple-negative breast cancer.
Kristen N Stevens, Celine M Vachon, Fergus J Couch. Cancer Res 2013
137
12

Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Xin Yang, Goska Leslie, Alicja Doroszuk, Sandra Schneider, Jamie Allen, Brennan Decker, Alison M Dunning, James Redman, James Scarth, Inga Plaskocinska,[...]. J Clin Oncol 2020
127
12

Cancer Statistics, 2021.
Rebecca L Siegel, Kimberly D Miller, Hannah E Fuchs, Ahmedin Jemal. CA Cancer J Clin 2021
12

Screening MR imaging versus screening ultrasound: pros and cons.
Mary C Mahoney, Mary S Newell. Magn Reson Imaging Clin N Am 2013
11
12

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.